Market Overview
The market for bone and joint health ingredients is anticipated to grow at a 7.69% CAGR and reach USD 28,481.78 million in value by 2027. The increasing prevalence of bone and joint disorders and the rising demand for bone and joint health ingredients among the elderly population in functional foods, beverages, and dietary supplements are both factors contributing to the growth of the global market for bone and joint health ingredients.

However, growing consumer knowledge of the negative consequences of goods containing ingredients for bone and joint health could slow market expansion. Additionally, the developing markets for ingredients that promote bone and joint health present potential chances for market expansion in the future.

The market is anticipated to expand because of the rising demand for bone and joint health elements in functional food, beverages, and dietary supplements, rising demand from the older population, and the rising prevalence of orthopedic illnesses.

However, concerns including adverse reactions to the components for bones and joints and strict government regulations are anticipated to impede market expansion. However, it is anticipated that untapped markets in developing nations, development strategies by important companies, the influence of social media, and creative marketing techniques will lead to profitable expansion.

Segment Overview
The market for ingredients for bone and joint health has been divided into categories based on type, including calcium, collagen, glucosamine, chondroitin, magnesium, and vitamins.

The global market for bone and joint health ingredients has been divided into three application groups: pharmaceuticals, food and beverage, and nutraceuticals & dietary supplements. In 2020, the Nutraceuticals & Dietary Supplements segment held a higher market share of 65.55%, and it is anticipated to experience the greatest CAGR of 8.60% during the following five years.

Regional Analysis
By area, the worldwide Bone and joint health ingredient market have been partitioned into North America, Europe, Asia-Pacific, and the Remainder of the World.

Asia-Pacific is projected to expand at a 8.20% most noteworthy CAGR during the figure time frame. Asia-Pacific is expected to enlist the most noteworthy development rate over the gauge period from this is because of the great frequency of joint pain and osteoporosis, further developing healthcare, expanding per capita extra cash, and expanding bone and joint health mindfulness. Numerous grown-ups dwelling in the district are supposed to experience the ill effects of different muscular problems.

Europe represented the second-biggest market portion of 28.80% of the Bone and joint health ingredient market in 2020. The local market is supposed to enroll a CAGR of 7.07% during the estimate time frame. Europe is expected to observe critical development over the gauge period because of a bigger number of patients experiencing bone and joint-related messes, the accessibility of items in the district, and the developing geriatric populace. The quantity of hip and knee substitution methods has expanded quickly in most OECD nations.

Major Players
Prominent players in the global Bone and joint health ingredient market include DSM (Netherlands), Stratum Nutrition (US), BASF SE (Germany), Archer-Daniels-Midland Company (ADM) (US), s (Ireland), Holista Colltech (Australia), Lonza Group (Switzerland), PharmaZen Limited (New Zealand), Darling Ingredients (US), Bioiberica S.A.U. (Spain).

COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 13

2 MARKET INTRODUCTION 14

2.1 SCOPE OF THE STUDY 14

2.2 RESEARCH OBJECTIVE 14

2.3 MARKET STRUCTURE 14

2.4 ASSUMPTIONS & LIMITATIONS 15

3 RESEARCH METHODOLOGY 16

3.1 DATA MINING 16

3.2 SECONDARY RESEARCH 17

3.3 PRIMARY RESEARCH 18

3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19

3.5 FORECASTING TECHNIQUES 19

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS 24

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 GROWING DEMAND FOR BONE AND JOINT HEALTH INGREDIENTS IN FUNCTIONAL

FOOD & BEVERAGES AND DIETARY SUPPLEMENTS 25

4.2.2 RISING DEMAND FOR BONE AND JOINT HEALTH INGREDIENTS IN THE ELDERLY POPULATION 25

4.2.3 RISING PREVALENCE OF ORTHOPEDIC DISEASES 26

4.3 RESTRAINT 27

4.3.1 SIDE EFFECTS ASSOCIATED WITH THE BONE AND JOINT INGREDIENTS 27

4.3.2 STRINGENT GOVERNMENT REGULATIONS 27

4.4 OPPORTUNITY 28

4.4.1 UNTAPPED MARKETS IN DEVELOPING ECONOMIES 28

4.4.2 ADOPTION OF GROWTH STRATEGIES BY KEY PLAYERS 29

4.4.3 INFLUENCE OF SOCIAL MEDIA AND INNOVATIVE MARKETING STRATEGIES 29

5 MARKET FACTOR ANALYSIS 30

5.1 VALUE CHAIN ANALYSIS 30

5.1.1 R&D 31

5.1.2 MANUFACTURING 31

5.1.3 DISTRIBUTION 31

5.1.4 MARKETING AND SALES 31

5.2 PORTER’S FIVE FORCES MODEL 32

5.2.1 THREAT OF NEW ENTRANTS 33

5.2.2 BARGAINING POWER OF SUPPLIERS 33

5.2.3 THREAT OF SUBSTITUTES 33

5.2.4 BARGAINING POWER OF BUYERS 33

5.2.5 INTENSITY OF RIVALRY 33

5.3 COVID-19 IMPACT ANALYSIS 34

5.3.1 IMPACT ON R&D 34

5.3.2 IMPACT ON SUPPLY CHAIN 34

5.3.3 IMPACT ON RAW MATERIAL 34

5.3.4 IMPACT ON DEMAND AND SUPPLY 35

6 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY INGREDIENT TYPE 36

6.1 OVERVIEW 36

6.2 CALCIUM 37

6.3 COLLAGEN 39

6.4 GLUCOSAMINE 40

6.5 CHONDROITIN 41

6.6 MAGNESIUM 42

6.7 VITAMINS 43

6.8 OTHERS 45

7 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY APPLICATION 46

7.1 OVERVIEW 46

7.2 FOOD & BEVERAGES 47

7.3 PHARMACEUTICALS 48

7.4 NUTRACEUTICALS & DIETARY SUPPLEMENTS 49

8 GLOBAL BONE AND JOINT HEALTH INGREDIENT MARKET, BY REGION 50

8.1 OVERVIEW 50

8.2 NORTH AMERICA 52

8.2.1 US 54

8.2.2 CANADA 55

8.2.3 MEXICO 56

8.3 EUROPE 57

8.3.1 GERMANY 59

8.3.2 UK 60

8.3.3 FRANCE 61

8.3.4 ITALY 62

8.3.5 SPAIN 63

8.3.6 REST OF EUROPE 64

8.4 ASIA PACIFIC 65

8.4.1 CHINA 67

8.4.2 JAPAN 68

8.4.3 INDIA 69

8.4.4 AUSTRALIA & NEW ZEALAND 70

8.4.5 REST OF ASIA-PACIFIC 71

8.5 REST OF THE WORLD 72

8.5.1 SOUTH AMERICA 74

8.5.2 MIDDLE EAST 75

8.5.3 AFRICA 76

9 COMPETITIVE LANDSCAPE 77

9.1 OVERVIEW 77

9.2 COMPETITIVE BENCHMARKING 79

9.3 MAJOR GROWTH STRATEGY IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 80

9.4 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN THE BONE AND JOINT HEALTH INGREDIENT MARKET 81

9.5 KEY DEVELOPMENT ANALYSIS 81

9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 82

9.6.1 PRODUCT LAUNCH/ APPROVAL 82

9.6.2 COLLABORATION/EXPANSION/INVESTMENT/PARTNERSHIP 82

9.6.3 MARKET PROMOTION/PRODUCT RECOGNITION/PRODUCT INCORPORATION 83

9.7 FINANCIAL MATRIX 84

9.7.1 SALES (USD MILLION), 2020 84

9.7.2 R&D EXPENDITURE (USD MILLION), 2020 84

10 COMPANY PROFILES 85

10.1 KONINKLIJKE DSM N.V. (ROYAL DSM) 85

10.1.1 COMPANY OVERVIEWS 85

10.1.2 FINANCIAL OVERVIEW 86

10.1.3 PRODUCTS/SERVICES OFFERED 87

10.1.4 KEY DEVELOPMENTS 87

10.1.5 SWOT ANALYSIS 88

10.1.6 KEY STRATEGIES 88

10.2 BASF SE 89

10.2.1 COMPANY OVERVIEW 89

10.2.2 FINANCIAL OVERVIEW 90

10.2.3 PRODUCTS/SERVICES OFFERED 90

10.2.4 KEY DEVELOPMENTS 91

10.2.5 SWOT ANALYSIS 91

10.2.6 KEY STRATEGIES 91

10.3 ARCHER DANIELS MIDLAND 92

10.3.1 COMPANY OVERVIEWS 92

10.3.2 FINANCIAL OVERVIEW 93

10.3.3 PRODUCTS/SERVICES OFFERED 93

10.3.4 KEY DEVELOPMENTS 93

10.3.5 SWOT ANALYSIS 94

10.3.6 KEY STRATEGIES 94

10.4 GLANBIA PLC 95

10.4.1 COMPANY OVERVIEWS 95

10.4.2 FINANCIAL OVERVIEW 96

10.4.3 PRODUCTS/SERVICES OFFERED 96

10.4.4 KEY DEVELOPMENTS 97

10.4.5 SWOT ANALYSIS 97

10.4.6 KEY STRATEGIES 97

10.5 LONZA GROUP 98

10.5.1 COMPANY OVERVIEWS 98

10.5.2 FINANCIAL OVERVIEW 99

10.5.3 PRODUCTS/SERVICES OFFERED 99

10.5.4 KEY DEVELOPMENTS 100

10.5.5 SWOT ANALYSIS 101

10.5.6 KEY STRATEGIES 101

10.6 BIOIBERICA S.A.U. 102

10.6.1 COMPANY OVERVIEWS 102

10.6.2 FINANCIAL OVERVIEW 102

10.6.3 PRODUCTS/SERVICES OFFERED 102

10.6.4 KEY DEVELOPMENTS 103

10.6.5 SWOT ANALYSIS 103

10.6.6 KEY STRATEGIES 104

10.7 STRATUM NUTRITION 105

10.7.1 COMPANY OVERVIEW 105

10.7.2 FINANCIAL OVERVIEW 105

10.7.3 PRODUCTS/SERVICES OFFERED 105

10.7.4 KEY DEVELOPMENTS 105

10.7.5 KEY STRATEGIES 105

10.8 PHARMAZEN LIMITED (WAITAKI BIO) 106

10.8.1 COMPANY OVERVIEW 106

10.8.2 FINANCIAL OVERVIEW 106

10.8.3 PRODUCTS/SERVICES OFFERED 107

10.8.4 KEY DEVELOPMENTS 107

10.8.5 KEY STRATEGIES 107

10.9 DARLING INGREDIENTS (ROUSSELOT) 108

10.9.1 COMPANY OVERVIEW 108

10.9.2 FINANCIAL OVERVIEW 109

10.9.3 PRODUCTS/SERVICES OFFERED 109

10.9.4 KEY DEVELOPMENTS 110

10.9.5 KEY STRATEGIES 110

10.10 HOLISTA COLLTECH 111

10.10.1 COMPANY OVERVIEWS 111

10.10.2 FINANCIAL OVERVIEW 112

10.10.3 PRODUCTS/SERVICES OFFERED 112

10.10.4 DEVELOPMENTS 113

10.10.5 KEY STRATEGIES 113

11 APPENDIX 114

11.1 REFERENCES 114

11.2 RELATED REPORTS 114

The post Bone And Joint Health Ingredient Market Global Research Report Forecast till 2027 first appeared on CRI Report.